A detailed history of Intech Investment Management LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Intech Investment Management LLC holds 7,075 shares of CORT stock, worth $534,445. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,075
Holding current value
$534,445
% of portfolio
0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

BUY
$67.17 - $83.9 $475,227 - $593,592
7,075 New
7,075 $588,000
Q1 2025

May 20, 2025

BUY
$49.85 - $114.22 $729,205 - $1.67 Million
14,628 Added 28.07%
66,735 $7.62 Million
Q4 2024

Feb 10, 2025

BUY
$44.66 - $60.85 $1.41 Million - $1.92 Million
31,575 Added 153.78%
52,107 $2.63 Million
Q3 2024

Nov 08, 2024

BUY
$29.51 - $46.26 $181,191 - $284,036
6,140 Added 42.66%
20,532 $949,000
Q2 2024

Aug 12, 2024

BUY
$22.21 - $34.48 $319,646 - $496,236
14,392 New
14,392 $467,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $8.09B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.